Enalapril Maleate Tablet
Product Images NDC 23155-705

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Enalapril Maleate (NDC 23155-705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 01

FDA Label Image

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 02

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 02
This appears to be a table organized in rows and columns showing the incidence of adverse effects in patients taking Enatapril versus Placebo. The adverse effects are grouped by body system including the body as a whole, cardiovascular, digestive, nervous-psychiatric, respiratory, skin, and urogenital. The table also shows the number of discontinuations due to each adverse effect.*
FDA Label Image

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 03

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 03
This text appears to be a table or chart indicating initial doses of creatinine to administer depending on the patient's renal status and clearance. It also mentions adjusting dosage on nondialysis days based on blood pressure response. There is a warning about anaphylactoid reactions during membrane exposure. Additionally, there is a specific dosage recommendation for dialysis patients.*
FDA Label Image

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 04

FDA Label Image

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 05

FDA Label Image

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 06

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 06
Avet Pharma Enalapril Maleate Tablets USP is a pack of 100 tablets, with each tablet containing enalapril maleate as its major active ingredient. The product is manufactured and distributed by Avet Pharma. The exact indications and dosage for the product are not provided in the text.*
FDA Label Image

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 07

FDA Label Image

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 08

FDA Label Image

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 09

FDA Label Image

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 10

37366051 Ccb9 4ce6 9060 0d4fa9e00a66 10
This appears to be some sort of invoice with various codes, numbers, and product descriptions. However, no further information is provided about the invoice or the products.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.